Lyell Immunopharma | SC 13G/A:超过5%持股股东披露文件(修正)-ARCH Venture Fund IX, L.P.(14.5%),ARCH Venture Fund IX Overage, L.P.(14.5%)等
02/14 15:24 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Lang Matthew
02/13 20:31 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Hill Stephen J.
02/13 20:26 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Lee Gary K.
02/13 20:26 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Newton Charles W.
02/13 20:21 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Seely Lynn
02/13 20:21 (美东)
Lyell Immunopharma | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(5.40%)
02/13 17:52 (美东)
Lyell Immunopharma | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.7%)
01/29 17:37 (美东)
Lyell Immunopharma | 4:持股变动声明-首席财务官 Newton Charles W.
2023/11/20 20:55 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Lee Gary K.
2023/11/20 20:54 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Seely Lynn
2023/11/20 20:53 (美东)
Lyell Immunopharma | 4:持股变动声明-高管 Hill Stephen J.
2023/11/20 20:52 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 Klausner Richard
2023/09/08 16:30 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 RIEFLIN WILLIAM JL
2023/09/08 16:27 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 FRIEDMAN CATHY
2023/09/08 16:26 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 NELSEN ROBERT
2023/09/08 16:24 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 NABEL ELIZABETH G
2023/09/08 16:23 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 BRAWLEY OTIS W
2023/09/08 16:22 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 Bishop Hans Edgar
2023/09/08 16:20 (美东)
Lyell Immunopharma | 4:持股变动声明-董事 Klausner Richard
2023/08/17 16:23 (美东)
暂无数据
暂无数据